Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022

BUY
$3.43 - $5.62 $274,400 - $449,600
80,000 Added 79.56%
180,555 $812,000
Q2 2022

Aug 01, 2022

BUY
$3.65 - $7.3 $18,250 - $36,500
5,000 Added 5.23%
100,555 $402,000
Q1 2022

Apr 27, 2022

BUY
$3.4 - $7.88 $245,497 - $568,975
72,205 Added 309.23%
95,555 $699,000
Q4 2021

Jan 31, 2022

BUY
$5.59 - $7.39 $7,546 - $9,976
1,350 Added 6.14%
23,350 $131,000
Q2 2021

Jul 20, 2021

BUY
$6.71 - $11.04 $147,620 - $242,879
22,000 New
22,000 $185,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0

About Provention Bio, Inc.


  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track 1900 Wealth Management LLC Portfolio

Follow 1900 Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1900 Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on 1900 Wealth Management LLC with notifications on news.